NEW YORK (GenomeWeb News) – Roche today said that the US Food and Drug Administration approved a new workflow process for the company's Cobas HPV test.

The newly approved workflow option allows for a sample to be processed from the primary sample collection vial directly after it has been used for cytology testing. This allows laboratories to load the same vial used for a ThinPrep Pap test onto the Cobas 4800 system for high-risk human papillomavirus and individual HPV 16 and HPV 18 genotype testing, Roche said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.